(Q39655433)

13 September 2017

title

AAV-P125A-endostatin and paclitaxel treatment increases endoreduplication in endothelial cells and inhibits metastasis of breast cancer (English)

1 reference

13 September 2017

0 references

1 reference

I V Subramanian

1

1 reference

13 September 2017

S Devineni

2

1 reference

13 September 2017

R Ghebre

3

1 reference

13 September 2017

G Ghosh

4

1 reference

13 September 2017

H P Joshi

5

1 reference

13 September 2017

Y Jing

6

1 reference

13 September 2017

A M Truskinovsky

7

1 reference

13 September 2017

S Ramakrishnan

8

1 reference

13 September 2017

language of work or name

1 reference

16 September 2010

1 reference

13 September 2017

1 reference

13 September 2017

volume

18

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

145-154

1 reference

Angiogenesis: A Marker for Neoplastic Transformation of Mammary Papillary Hyperplasia

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Targeting angiogenesis in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Therapeutic efficacy of recombinant human endostatin combined with chemotherapeutics in mice-transplanted tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

beta-Catenin is a Nek2 substrate involved in centrosome separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Identification of a role for beta-catenin in the establishment of a bipolar mitotic spindle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

NEDD1-dependent recruitment of the gamma-tubulin ring complex to the centrosome is necessary for centriole duplication and spindle assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Endostatin is a potential inhibitor of Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Improved biological activity of a mutant endostatin containing a single amino-acid substitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Addition of integrin binding sequence to a mutant human endostatin improves inhibition of tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Endostatin's antiangiogenic signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Multinuclear giant cell formation is enhanced by down-regulation of Wnt signaling in gastric cancer cell line, AGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

The anti-angiogenic basis of metronomic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Assessment of endostatin gene therapy for familial adenomatous polyposis-related desmoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Binding of endostatin to human ovarian cancer cells inhibits cell attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Endostatin binding to ovarian cancer cells inhibits peritoneal attachment and dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Successful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Adeno-associated virus-mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Adeno-associated virus-mediated delivery of a mutant endostatin in combination with carboplatin treatment inhibits orthotopic growth of ovarian cancer and improves long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

VEGF-DT385 toxin conjugate inhibits mammary adenocarcinoma development in a transgenic mouse model of spontaneous tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

inferred from DOI database lookup

7 January 2021

based on heuristic

Microvessel density and distribution in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

inferred from DOI database lookup

7 January 2021

based on heuristic

Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.118

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2010.118

1 reference

13 September 2017

1 reference